SIGLEC9
Reaktivität: Human
WB
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1.0 mg/mL
Avril, Floyd, Lopez, Vivier, Crocker et al.: "The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK ..." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 173, Issue 11, pp. 6841-9, (2004) (PubMed).
Zhang, Nicoll, Jones, Crocker: "Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes." in: The Journal of biological chemistry, Vol. 275, Issue 29, pp. 22121-6, (2000) (PubMed).